Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

B. Riley Securities Maintains Buy on Identiv, Lowers Price Target to $6

Author: Benzinga Newsdesk | August 08, 2025 07:56am
B. Riley Securities analyst Craig Ellis maintains Identiv (NASDAQ:INVE) with a Buy and lowers the price target from $6.5 to $6.

Posted In: INVE

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist